Akoya Biosciences Inc (AKYA)
2.78
+0.22
(+8.81%)
USD |
NASDAQ |
Oct 04, 16:00
2.775
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Shareholders Equity (Annual): 53.77M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.77M |
| December 31, 2022 | 58.58M |
| December 31, 2021 | 121.35M |
| Date | Value |
|---|---|
| December 31, 2020 | -51.03M |
| December 31, 2019 | -30.16M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-51.03M
Minimum
2020
121.35M
Maximum
2021
30.50M
Average
53.77M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Bruker Corp | 1.377B |
| Azenta Inc | 2.534B |
| Harvard Bioscience Inc | 73.07M |
| Bionano Genomics Inc | 96.16M |
| Singular Genomics Systems Inc | 179.01M |